Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2008
05/20/2008CA2214685C Benzamidine derivatives their preparation and their use as anti-coagulants
05/20/2008CA2191874C Novel processes and intermediates for the preparation of piperazine derivatives
05/15/2008WO2008058198A1 Methods of making compounds having a beta-adrenergic inhibitor and a linker and methods of making compounds having a beta-adrenergic inhibitor, a linker and a phosphodiesterase inhibitor
05/15/2008WO2008058068A1 (r)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
05/15/2008WO2008058064A1 Amine-linked multicyclic compounds as inhibitors of the proline transporter
05/15/2008WO2008058037A1 Compounds and compositions as protein kinase inhibitors
05/15/2008WO2008057857A1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
05/15/2008WO2008057559A1 Processes for preparing substantially pure pantoprazole magnesium
05/15/2008WO2008057291A2 Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof
05/15/2008WO2008057280A1 Multi-cyclic compounds and methods of use
05/15/2008WO2008056687A1 Novel spiropiperidine derivative
05/15/2008WO2008056202A2 Desloratadine crystalline forms mixtures having a low level of residual solvents
05/15/2008WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008WO2008056148A1 Chemical compounds
05/15/2008WO2008055950A1 Novel inhibitors of glutaminyl cyclase
05/15/2008WO2008055947A1 Novel inhibitors of glutaminyl cyclase
05/15/2008WO2008055840A1 Thiazole and oxazole-substituted arylamides
05/15/2008WO2008055808A1 Indole and benzofuran 2-carboxamide derivatives
05/15/2008WO2008055710A1 Indole and indazole derivatives as anti-inflammatory agents
05/15/2008WO2008055709A1 Indazole and indole derivatives as anti -inflammatory agents
05/15/2008WO2008037789A8 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
05/15/2008WO2008037681A8 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl] ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc.
05/15/2008WO2008008310A3 Tyrosine kinase inhibitors
05/15/2008WO2007018941A3 Pyrimidyl-thiophene derivatives
05/15/2008US20080114174 Photoelectric conversion efficiency; commercial potential; increased solar spectrum absorption region; easy synthesis
05/15/2008US20080114158 Yellow anionic disazo dyes
05/15/2008US20080114052 Cyclic derivatives as modulators of chemokine receptor activity
05/15/2008US20080114034 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong
05/15/2008US20080114033 N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide; Met kinase inhibitor; hypatocyte growth factor antagonist; anticarcinogenic agent
05/15/2008US20080114030 Diarymethyl and related compounds
05/15/2008US20080114015 NF-kB inhibitors and uses thereof
05/15/2008US20080114013 Spiroindolinone derivatives
05/15/2008US20080114007 8-indan-5-yl-5-oxo-2-(3-piperazin-1-yl-phenylamino)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid isopropylamide; antiinflammatory, anticarcinogenic agent, cardiovascular disease; glomerulonephritis, immune nephritis, rheumatoid arthritis, asthma, pancreatitis, HIV infection, psoriasis
05/15/2008US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies
05/15/2008US20080114004 Hydrazone derivatives as kinase inhibitors
05/15/2008US20080113985 Modulators of ATP-binding cassette transporters
05/15/2008US20080113983 (N (R)-1-Azabicyclo[2.2.2]oct-3-yl)-3-fluoro-5-phenylthiophene-2-carboxylic acid amide; antidepressant, anxiolytic, analgesic agent, cognition activator, attention disorders
05/15/2008US20080113971 improved potency; reduced undesirable side effects; pain, inflammation, arthritis etc; ethyl 1-(2-aminoethyl)-3-pyridin-4-yl-1H-pyrazole-5-carboxylate dihydrochloride
05/15/2008US20080113968 Substituted piperazines and diazepanes
05/15/2008US20080113967 Enzyme modulators and treatments
05/15/2008US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use
05/15/2008US20080113944 Novel Indole Derivatives
05/15/2008US20080112866 Functionalized ionic liquids, and methods of use thereof
05/15/2008CA2669034A1 Chemical compounds
05/15/2008CA2668959A1 Indole and benzofuran 2-carboxamide derivatives
05/15/2008CA2668899A1 (r)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
05/15/2008CA2668853A1 Novel triazinedione derivatives as gaba-b receptor modulators
05/15/2008CA2668785A1 Heterocyclyc sulfonamides having edg-i antagonistic activity
05/15/2008CA2668399A1 Thiazole and oxazole-substituted arylamides
05/15/2008CA2668190A1 Compounds and compositions as protein kinase inhibitors
05/15/2008CA2641668A1 Desloratadine crystalline forms mixtures having a low level of residual solvents
05/14/2008EP1921075A2 A process for the preparation of pyridine-methylsulfinyl compounds
05/14/2008EP1921068A1 Indazole and indole derivatives as anti-inflammatory agents
05/14/2008EP1921067A1 Indole and indazole derivatives as anti-inflammatory agents
05/14/2008EP1921066A1 Pyridylphenol compound and use thereof
05/14/2008EP1921059A2 Highly nucleated thermoplastic articles
05/14/2008EP1920773A1 Compositions for inhibition of anglogenesis
05/14/2008EP1919928A1 Platinum complex compound and organic electroluminescent device
05/14/2008EP1919906A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
05/14/2008EP1919905A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-recptor tyrosine kinases
05/14/2008EP1919904A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919903A2 Bicyclic bisamide derivatives and use thereof as insecticides
05/14/2008EP1919902A2 Novel processes for the production of amorphous rabeprazole sodium
05/14/2008EP1919901A1 Substituted piperazines as metabotropic glutamate receptor antagonists
05/14/2008EP1919900A2 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
05/14/2008EP1919899A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919898A1 Macrocyclic inhibitors of hepatitis c virus
05/14/2008EP1919897A1 Method of preparing esomeprazole and salts thereof
05/14/2008EP1919896A1 Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands.
05/14/2008EP1919895A2 2-aminoaryl pyridines as protein kinases inhibitors
05/14/2008EP1919894A2 Novel polyquinoline derivatives and the therapeutic use thereof
05/14/2008EP1919893A2 Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
05/14/2008EP1919892A2 Isoindole-imide compounds and compositions comprising and methods of using the same
05/14/2008EP1919891A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
05/14/2008EP1919890A1 Pyrazolone derivatives for the treatment of tuberculosis
05/14/2008EP1919884A1 N-benzyl-morpholine derivatives as modulators of the chemokine receptor
05/14/2008EP1919881A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders
05/14/2008EP1919875A2 Pyrazole derivatives and their use as pka and pkb modulators
05/14/2008EP1919869A1 Novel indole compounds
05/14/2008EP1919865A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
05/14/2008EP1667991B1 Quinazoline derivatives as tyrosine kinase inhibitors
05/14/2008EP1606277B1 Imidazol-4-yl-ethynyl-pyridine derivatives
05/14/2008EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
05/14/2008EP1446375B1 Dihalogenpropene compounds, method for the production thereof, agents containing said compounds and the use thereof as pest control agents
05/14/2008CN101180296A Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
05/14/2008CN101180291A Benzimidazole-carboxamide compounds as 5-ht4, receptor agonists
05/14/2008CN101180278A 2-amino-4-phenylquinazoline derivates and their use as HSP90 modulators
05/14/2008CN101180269A Method of preparing 3-cyano-quinolines and intermediates made thereby
05/14/2008CN101177385A Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease
05/14/2008CN100388201C Program code size partitioning system and method for multiple memory multi-processing systems
05/14/2008CN100387594C Di-aryl substituted pyrazole modulators of metabotropic glutamate receptor-5
05/14/2008CN100387127C Fungicides
05/13/2008US7371868 Bactericides; 2-[(1R)-1-methyl-2-trityl-2,3-dihydro-1H-5-isoindolyl]-1,3,6,2-dioxazaborocane.
05/13/2008US7371768 A 1-aryl-3-cyano-5- pyridylalkylaminopyrazole derivatives, insecticides, chemical intermediates, haloalkylation
05/13/2008US7371767 Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
05/13/2008US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties
05/13/2008US7371765 Quinoline derivatives having VEGF inhibiting activity
05/13/2008US7371763 Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
05/13/2008US7371761 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
05/13/2008US7371759 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents
1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 1080